333 related articles for article (PubMed ID: 22580236)
1. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Yousif MH; Dhaunsi GS; Makki BM; Qabazard BA; Akhtar S; Benter IF
Pharmacol Res; 2012 Sep; 66(3):269-75. PubMed ID: 22580236
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.
Akhtar S; Chandrasekhar B; Attur S; Dhaunsi GS; Yousif MH; Benter IF
PLoS One; 2015; 10(11):e0141657. PubMed ID: 26536590
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
Shi Y; Lo CS; Padda R; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Clin Sci (Lond); 2015 May; 128(10):649-63. PubMed ID: 25495544
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with Ang-(1-7) reverses abnormal reactivity in the corpus cavernosum and normalizes diabetes-induced changes in the protein levels of ACE, ACE2, ROCK1, ROCK2 and omega-hydroxylase in a rat model of type 1 diabetes.
Yousif MH; Makki B; El-Hashim AZ; Akhtar S; Benter IF
J Diabetes Res; 2014; 2014():142154. PubMed ID: 25309930
[TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T
J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897
[TBL] [Abstract][Full Text] [Related]
6. Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
Ogata Y; Nemoto W; Yamagata R; Nakagawasai O; Shimoyama S; Furukawa T; Ueno S; Tan-No K
Eur J Pain; 2019 Apr; 23(4):739-749. PubMed ID: 30421564
[TBL] [Abstract][Full Text] [Related]
7. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
8. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
[TBL] [Abstract][Full Text] [Related]
9. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
Wong TP; Ho KY; Ng EK; Debnam ES; Leung PS
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E669-81. PubMed ID: 22811473
[TBL] [Abstract][Full Text] [Related]
11. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
[TBL] [Abstract][Full Text] [Related]
12. The ACE2/Ang-(1-7)/Mas Axis Regulates the Development of Pancreatic Endocrine Cells in Mouse Embryos.
Wang L; Liang J; Leung PS
PLoS One; 2015; 10(6):e0128216. PubMed ID: 26029927
[TBL] [Abstract][Full Text] [Related]
13. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
Benter IF; Yousif MH; Al-Saleh FM; Raghupathy R; Chappell MC; Diz DI
J Cardiovasc Pharmacol; 2011 May; 57(5):559-67. PubMed ID: 21326110
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7) inhibits vascular calcification in rats.
Sui YB; Chang JR; Chen WJ; Zhao L; Zhang BH; Yu YR; Tang CS; Yin XH; Qi YF
Peptides; 2013 Apr; 42():25-34. PubMed ID: 23291307
[TBL] [Abstract][Full Text] [Related]
16. Role of Mas receptor antagonist (A779) in renal hemodynamics in condition of blocked angiotensin II receptors in rats.
Mansoori A; Oryan S; Nematbakhsh M
Physiol Int; 2016 Mar; 103(1):13-20. PubMed ID: 27030624
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ACE2 in cardiac myocytes and fibroblasts.
Gallagher PE; Ferrario CM; Tallant EA
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2373-9. PubMed ID: 18849338
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
Kucharewicz I; Pawlak R; Matys T; Pawlak D; Buczko W
Hypertension; 2002 Nov; 40(5):774-9. PubMed ID: 12411476
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
Benter IF; Yousif MH; Anim JT; Cojocel C; Diz DI
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H684-91. PubMed ID: 16403946
[TBL] [Abstract][Full Text] [Related]
20. Vasodilator Effect of Angiotensin-(1-7) on Vascular Coronary Bed of Rats: Role of Mas, ACE and ACE2.
de Moraes PL; Kangussu LM; Castro CH; Almeida AP; Santos RAS; Ferreira AJ
Protein Pept Lett; 2017 Nov; 24(9):869-875. PubMed ID: 28758595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
